What Should We Feed?

Human Milk Fortifier (HMF)

What If Breast Milk Is Unavailable?
Optimizing Management
When Do We Stop Preterm Formula or HMF
Screening for Nutrition Risk in Preterm
Infants
Overview of EN Support in Special
Populations
The Working GI Tract
History of EEN
EN: Effective Induction Therapy
for Crohn’s Disease
Data
EN Utilization: Discrepancy
Proposed Mechanisms of Action
Concerns
Other Diets for IBD
Other Enteral Supplements
Summary
Overview of EN Support in Special
Populations
Short Bowel Syndrome (SBS)/Intestinal Failure
Proposed New Definition
Factors Affecting Patient Outcomes
Principles of Nutritional Care of SBS
Sites Of Absorption
Nutritional Consideration with Bowel Loss
Nutrition Therapy
Total Parenteral Nutrition
Benefit of Feeding Type in SBS
Frequency For Monitoring Growth
Children With SBS
Frequency For Monitoring Nutrient Status
In Children With SBS - I
Frequency For Monitoring Nutrient Status
In Children With SBS - II
What’s New
Omega 3 Fatty Acid Infusion
SBS Conclusion
Overview of EN Support in Special
Populations
EN: Cystic Fibrosis
Association Between BMI Percentile &
FEV1
Nutrient Requirements - I
Nutrient Requirements - II
Nutritional Management - I
Nutritional Management - II
Prevention of Nutritional Deficits:
Anticipatory Guidance
What to Do When Poor Growth is Identified
Interventions for Nutritional Failure
Tube Feeds – I
References
Bradley GM, Carson KA, Leonard AR, et al. Nutritional outcomes following gastrostomy in children with cystic fibrosis. Pediatr Pulmonol. 2012; Feb 1. doi: 10.1002/ppul.22507. [Epub
ahead of print]
Erskine JM, Lingard C, Sontag M. Update on enteral nutrition support for cystic fibrosis. Nutr Clin Pract. 2007;22(2):223-32.
Ramsey BW, Farrell PM, Pencharz P et al. Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee. Am J Clin Nutr. 1992;55(1) 108-16.

Tube Feeds - II
PERT and Tube Feeds
CFF Nutrition Guidelines for Infants
Summary
Overview of EN Support in Special
Populations
Nutrition & Cerebral Palsy
Goals & Benefits
Factors Resulting in Nutritional Deficits
Nutrition Assessment - I
Nutrition Assessment - II
Nutrition Assessment - III
Nutrition Assessment -IV
Determining the Nutritional Plan - I
Determining the Nutritional Plan - II
Determining the Nutritional Plan - III
Picking a Formula
Feeding Intolerance
Summary
Overview of EN Support in Special
Populations
Critical Illness and EN
Benefits of EN in an ICU Setting
Limitations of EN
When to Start EN
Starting EN: Lessons Learned
from Gastrointestinal Surgery
EN vs. PN
The Systemic Inflammatory Response
Syndrome:
Critical Illness Cycles: SIRS to CARS
(Compensatory Anti-inflammatory Response Syndrome)
Implications for EN
Critical Illness & Intermediary Metabolism
Implications for EN
Gastrointestinal Intolerance
Transpyloric EN (TEN)
EN and Gut Ischemia
Special Enteral Formula -
Immunomodulation
Special Enteral Formula - Glutamine
Special Enteral Formula -
Prebiotics and Probiotics
EN and Chylothorax
Overview of EN Support in Special
Populations
Causes of FTT
Initial Interventions in FTT
Oral Supplementation
EN and FTT
FTT: Benefits of Gastrostomy (GT)
Management of Children with Feeding Tubes
Cased-based Learning
Case Report
Case Report
Risk factor for Chronic intestinal failure which should trigger
involvement of multi professional team or intestinal rehabilitation
center
Case Report Continued
Conjugated Bilirubin
Case Report Continued
Case-based Learning
Case Study
Case Study (continued)
Case Study (continued)
Case Study- Follow-up